ORHub Inc. (ORHB) on a Mission to Optimize the Business of

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
326
ORHub Inc. (ORHB) on a Mission to Optimize the Business of Surgery

- Data analysis enables increased effectiveness, reduced costs and better outcomes for both surgeons and patients
- ORHub recently announced a stay of litigation as it works toward settlement of a contract litigation

ORHub Inc.’s (OTC: ORHB) Surgical Spotlight(R) cloud-based analytics tool for use in operating rooms is bound to optimize and transform the surgical business, as the company’s chief executive officer, Dr. Robert Lazzara, said in an exclusive interview with NetworkNewsAudio (http://nnw.fm/Si3G2).

The product allows administrators, surgeons and nurse leaders to make better decisions for the operating room on the basis of relevant data analysis. Surgical Spotlight(R) takes data feeds from the operating room information system and produces a functional dashboard aimed at identifying improvement opportunities. Beyond ensuring more effective operations, ORHub aims to deliver a solution that’s capable of reducing costs but also reliable in terms of improving outcomes for both patients and surgeons, Lazzara explained.

According to Lazzara, the introduction of such data-driven solutions could promote a health care transformation in the future. “By providing the information that allows for a change in behavior, control is put into the hands of surgeons and administrators, enabling the evaluation of trends, and empowering the facility to make instantaneous adjustments that will continue building efficiency and profitability on an ongoing basis,” he said.

ORHub is on a mission to maximize exposure, secure capital and drive revenue. At the same time, increasing awareness is expected to play a vital role in the widespread adoption of Surgical Spotlight(R). Empowerment through mentorship across the country could easily contribute to a paradigm shift that will eventually ensure modernization across the health care surgical service provision sector, Lazzara added.

ORHub’s mission is to place Surgical Spotlight(R) into as many operating rooms as possible. Currently, the company is relying on video streaming and digital platforms to increase awareness among both surgical team leaders and patients.

Since its launch in 2019, Surgical Spotlight(R) has continued gaining market traction and penetration. Right now, procedurally oriented specialties include the interventional cardiology lab, gastrointestinal lab and interventional radiology lab.

In other news, ORHub recently announced that it has negotiated a stay of litigation and is working toward a settlement (http://nnw.fm/aHdS8).

ORHub is a growth-stage data analytics company that aims to optimize surgical processes through lean process improvement. A Microsoft Silver Partner, the company utilizes the Azure cloud to help customers fully benefit from all data captured in the operating room.

Through its strategic work, ORHub has secured a number of crucial partnerships, like those with the Hoag Orthopedic Institute in the Province network, Anderson Regional Medical Center, Baptist Health in Jacksonville, Alvarado Hospital Medical Center in the Prime Network and Orthopedic Institute Surgery Center in the SMP network.

ORHub has presented Surgical Spotlight(R) at multiple events and conferences in 2019. The company has secured approval to present at nursing forums and offer 1.2 contact hours toward Continuing Education Units from Terri Goodman, RN, PhD, & Associates.

For more information, visit the company’s website at www.ORHub.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

ORHUB, Inc. (ORHB) Stock Research Links

ORHB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 37

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 28

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 32

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 36

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 30

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 23

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 36

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Technologies Unveiled by LG Innotek at CES 2025

Updated Category News Views 383

Innovative Showcase by LG Innotek at CES 2025 LG Innotek has exciting plans for CES 2025, showcasing its commitment to revolutionizing future mobility. This year, the company aims to highlight its advanced technologies at a well-organized exhibition booth set within the bustling West Hall. A Focus on Future Mobility Technologies At CES 2025, LG Innotek will present a...

Continue Reading
Alumis and ACELYRIN Merger: A New Era for Biopharma Innovation

Updated Category News Views 277

Alumis and ACELYRIN Merge to Forge a New Path in Biopharma The biopharmaceutical landscape is about to witness a significant transformation as Alumis Inc. (NASDAQ: ALMS) and ACELYRIN, INC. (NASDAQ: SLRN) announce their merger. This strategic alliance aims to innovate, develop, and commercialize new therapies for immune-mediated diseases. With top-tier clinical programs...

Continue Reading
Legal Reminder for ICON Shareholders: Act Before Deadline

Updated Category News Views 147

Important Update for ICON plc Shareholders In a significant legal development, shareholders of ICON plc need to be aware of a class action lawsuit that has implications for their investments. If you have incurred losses exceeding $100,000, it is essential to act swiftly, as the deadline for filing lead plaintiff applications is approaching. This lawsuit originates from...

Continue Reading
Corvus Pharmaceuticals to Showcase Innovations at Investment Event

Updated Category News Views 50

Corvus Pharmaceuticals to Present at Major Investment Conference BURLINGAME, Calif. — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a prominent name in the clinical-stage biopharmaceutical sector, is thrilled to announce that its president and CEO, Richard A. Miller, M.D., along with Jeffrey Arcara, the chief business officer, will be participating in one-on-one meetings...

Continue Reading
Discover Promising Dividend Stocks with Robust Growth Potential

Updated Category News Views 122

Exploring Reliable Dividend Stocks with Growth Potential Investors have found that dividend stocks generally offer a compelling annual return averaging 9.2% since 1973, showing less volatility than the broader market index. These investments can provide a steady income stream while also having a significant upside potential. In this article, we delve into three stocks...

Continue Reading